Zobrazeno 1 - 10
of 93
pro vyhledávání: '"Gunnar Larsen"'
Autor:
Ebbe Billmann Thorgersen MD, PhD, Jørund Asvall MD, Camilla Schjalm MSc, Karin Ekholt McAdam MSc, Øyvind Sverre Bruland MD, PhD, Stein Gunnar Larsen MD, PhD, Tom Eirik Mollnes MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 22 (2023)
Despite extensive treatment with surgery and chemotherapy many patients with peritoneal metastases from colorectal cancer experience intraperitoneal disease relapse. The α-emitting 224 radium-labelled microparticle radionuclide therapeutic Radspheri
Externí odkaz:
https://doaj.org/article/f6dafb81dc0f4fb0b56067eb5142f031
Autor:
Stein Gunnar Larsen, Wilhelm Graf, Anthony Burton Mariathasan, Olaf Sørensen, Milan Spasojevic, Mariusz Adam Goscinski, Silje Selboe, Nadja Lundstrøm, Anne Holtermann, Mona-Elisabeth Revheim, Øyvind Sverre Bruland
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
BackgroundPeritoneal metastasis (PM) from colorectal cancer carries a dismal prognosis despite extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). With a median time to recurrence of 11–12 months, there is a n
Externí odkaz:
https://doaj.org/article/a8677dc49f144701a7b580b9fa722d54
Autor:
Simen Rykkje Grønningsæter, Johan Blakkisrud, Silje Selboe, Mona-Elisabeth Revheim, Øyvind Sverre Bruland, Tina Bjørnlund Bønsdorff, Stein Gunnar Larsen, Caroline Stokke
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
AimTwo ongoing phase I studies are investigating the use of radium-224 adsorbed to calcium carbonate micro particles (224Ra-CaCO3-MP) to treat peritoneal metastasis originating from colorectal or ovarian cancer. The aim of this work was to study the
Externí odkaz:
https://doaj.org/article/b0d173692f8d4056b9aa21a0313d575f
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-5 (2018)
Abstract Background Diagnostic work-ups in transplanted immunosuppressed patients are a challenge as non-specific findings may be interpreted as transplant-related complications. If the disease in question is rare and slowly developing like pseudomyx
Externí odkaz:
https://doaj.org/article/cc79d0db703a44699e6736b84bca38cb
Autor:
Arne M. Solbakken, Simen Sellevold, Milan Spasojevic, Lars Julsrud, Hanne-Line Emblemsvåg, Henrik Reims, Olaf Sørensen, Ebbe Billmann Thorgersen, Lena Fauske, Bjørn Brennhovd, Truls Ryder, Stein Gunnar Larsen, Kjersti Flatmark
Publikováno v:
European Journal of Surgical Oncology. 49:e50-e51
Autor:
Stein Gunnar Larsen, Janne-Merete T. Oien, Øystein Fodstad, Svein Dueland, Lars Julsrud, Kjersti Flatmark, Ida S. Frøysnes, Yvonne Andersson, Ben Davidson
Publikováno v:
European Journal of Surgical Oncology. 47:134-138
Background The ImmunoPeCa trial investigated the use of intraperitoneal MOC31PE immunotoxin as a novel therapeutic principle for the treatment of peritoneal metastasis from colorectal cancer (PM-CRC). We here report long-term outcome from the trial.
Autor:
David Swanson, Norman J. Carr, Thale Dawn J.H. Patrick-Brown, Kjersti Flatmark, Stein Gunnar Larsen, Faheez Mohamed
Publikováno v:
Annals of Surgical Oncology
Background The determination of the incidence and prevalence of rare diseases is important for economists and health-care providers. Pseudomyxoma peritonei (PMP) is a rare, slow-growing abdominal cancer that represents a substantial burden on both pa
Autor:
Olaf Sørensen, Kjersti Flatmark, Stein Gunnar Larsen, Karl Erik Giercksky, Anders Mikal Andersen
Publikováno v:
Clinical & Experimental Metastasis
Pseudomyxoma peritonei (PMP) is a rare cancer commonly originating from appendiceal neoplasms that presents with mucinous tumor spread in the peritoneal cavity. Patients with PMP are treated with curative intent by cytoreductive surgery (CRS) and hyp
Autor:
Eirik Malinen, Jan-Åge Olsen, Kathinka S Slørdahl, Stein Kaasa, Eva Skovlund, Marianne Grønlie Guren, Morten Brændengen, Arild Nesbakken, Dagmar Klotz, Laila Holmboe, Christine Undseth, Anita Sveen, Ragnhild Tvedt, Bettina Hanekamp, Heidi Larsen Abildgaard, Stein Gunnar Larsen, Ragnhild A. Lothe
Publikováno v:
Acta oncologica (Stockholm, Sweden). 60(7)
Background Squamous cell carcinoma of the anus (SCCA) is a rare malignancy with rising incidence, associated with human papilloma virus (HPV). Chemoradiotherapy (CRT) is the preferred treatment. The purpose was to investigate treatment failure, survi
Autor:
Lars Frich, Anthony B. Mariathasan, Stephan Stoldt, Øyvind S. Bruland, Stein Gunnar Larsen, Milan Spasojevic
Publikováno v:
Tidsskrift for Den norske legeforening.
For locally advanced soft tissue sarcomas and metastases from melanoma located in the extremities, mutilating surgery or amputation may be necessary to achieve local control. Isolated limb perfusion with high-dose chemotherapy may represent an altern